Enzolytics Inc (ENZC)

[suny66]

Seems odd indeed that just when Enzolytics begins to introduce IPF in the US market, the FDA all of a sudden changes it's policy on the acceptance of NDI's. This is nothing but an orchestrated strategy to protect Tamiflu sales and prevent the sales of IPF Immune in the US.
https://www.fda.gov/food/cfsan-constituent-updates/fda-releases-draft-guidance-ndi-enforcement-discretion